Law firm Maurice Blackburn revealed on Monday that it will appeal against an Australian court decision that backed Myriad Genetics’ ownership of a human gene mutation linked to breast cancer.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Myriad, appeal, gene patent, BRCA1, Maurice Blackburn
